MYRLANDE METELLUS: Open Payments
NPI 1346920899 · PHILLIPSBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $259 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: MOUNJARO, FARXIGA, Wegovy, REXULTI.
Industry payments across NJ — which companies pay providers there.
